Nootropics Index - Save on smarter supplements
Nootropics>Botanical & herbal supplements>Cranberry
Botanical & herbal supplements

Cranberry

Vaccinium macrocarpon fruit, juice and PAC-standardized extracts

Cranberry is a fruit, juice and extract ingredient best known for urinary-tract research, not nootropic effects. Evidence is strongest for reducing recurrent symptomatic UTI risk in some groups, especially women with recurrent UTIs, and it does not replace diagnosis or antibiotics when needed. For supplement buyers, the important comparisons are product form, A-type proanthocyanidin (PAC) standardization, whether the dose is PAC or total extract weight, sugar load in juices, testing quality, kidney-stone history, and warfarin or anticoagulant-drug review.

Antioxidant PathwaysMicrobiome RelatedWhole HerbStandardized ExtractWater ExtractFood DerivedTraditional Use
Updated August 2026/6 min read/9 citations
Reviewed by the NootropicsIndex editorial team.Method: prioritize cited human research and official safety or regulatory sources; compare retailer-listed prices without endorsing products.Affiliate disclosure
01

What is it?

What cranberry products are

1

Cranberry supplements can be juice, juice concentrate, whole-fruit powder, extract tablets or PAC-standardized capsules. The form matters because sugar, PAC content and adherence differ.

Not a nootropic page3
Cranberry's best clinical evidence is urinary-tract related. It should not be presented as a memory, focus, mood or productivity supplement.

Forms are not interchangeable

6

A cranberry juice beverage, whole-fruit powder and PAC-standardized capsule can have very different active-marker amounts, sugar load, serving size and price.

Recurrent UTI risk is the relevant evidence area3
Cochrane and subsequent analyses support a cautious recurrent-UTI risk-reduction framing in selected populations. This is different from nootropic efficacy.
Population matters3
Evidence is not equally strong for every group or product. Women with recurrent UTIs, older adults, children, catheter users and people with active symptoms need different clinical context.
02

Names, aliases and forms

Common NamesCranberry; American cranberry
Latin NameVaccinium macrocarpon
Plant PartFruit
Active ConstituentsA-type proanthocyanidins; PACs
Extract NamesCranberry extract; Cranberry juice concentrate
03

Mechanisms of action

A-type PAC anti-adhesion context

4

Cranberry PACs are studied for effects on bacterial adhesion in urinary-tract contexts. This mechanism does not imply acute brain stimulation or cognitive enhancement.

04

Potential effects and evidence map

Cranberry has clinical evidence and regulatory discussion for reducing recurrent UTI risk. One small 12-week feasibility RCT in healthy older adults reported a visual episodic-memory and regional-perfusion signal, but it does not establish a reliable cognitive-enhancement effect. Cochrane and later analyses point to form, population and adherence differences. The page separates urinary-tract evidence from broad brain claims and compares PAC-standardized capsules, whole-fruit powder and juice products carefully.

Effect domainMagnitudeGrade
Focus / attention3
UnknownConfidence: High

Cranberry does not have good human evidence for improving focus or productivity.

Note Urinary-tract evidence should not be converted into nootropic claims.

0/5
E
Memory / learning9
CumulativeConfidence: Low

In a 12-week placebo-controlled feasibility RCT of 60 healthy adults aged 50-80, freeze-dried cranberry powder was associated with improved visual episodic-memory performance. This single small study does not establish a reliable cognitive benefit.

Note A cautious, population-specific signal only; do not generalize it to broad nootropic benefit.

1/5
C
Cellular / long-term brain support9
CumulativeConfidence: Low

The same feasibility RCT reported regional brain-perfusion findings; this preliminary signal does not establish meaningful brain support.

Note A cautious, population-specific signal only; do not infer durable brain support.

1/5
C
05

Typical dosages and timing

standardized extracts437 mg/day PAC

A 24-week RCT compared 37 mg/day with 2 mg/day in healthy adult women with recurrent UTI history. The overall comparison was not statistically significant, so this is studied dose context—not a universal product target. Many products list total extract weight without a comparable PAC assay.

06

Timing & effect horizon

Effect horizonCumulative
Cumulative
Study window4Cumulative
24 weeks
Not an acute rescue product3

Cranberry studies usually evaluate recurrent-risk patterns over weeks or months. It should not be positioned as immediate care for active urinary symptoms.

07

Safety, side effects and risk profile

Warfarin and anticoagulant-drug review7
People using warfarin or other anticoagulant drugs should ask a clinician before high-dose cranberry extracts or large daily juice intakes. The evidence is mixed, so the safest buying-page advice is review rather than alarm.
Kidney-stone history deserves caution7
Cranberry products can affect urinary stone-risk factors in susceptible people. Anyone with recurrent kidney stones should compare dose, form and clinician advice before high-dose use.
Pregnancy and breastfeeding: supplement-dose uncertainty1
NCCIH notes that food amounts may be safe during pregnancy or breastfeeding, but evidence for larger supplemental amounts is inconclusive. This is a targeted uncertainty, not a general avoidance finding.
GI discomfort1
Confidence: Medium

Cranberry is usually well tolerated, but juice and extracts can cause GI upset in some users.

Note Sugar load and acidic juice can matter for tolerability.

1/5
B
Liver / kidney caution7
Confidence: Medium

People with kidney-stone history should review cranberry use because oxalate and stone-risk discussions are product- and dose-dependent.

Note Do not overstate; keep as caution for susceptible users.

1/5
C
Evidence uncertainty3
Confidence: High

Evidence depends heavily on product form, population, adherence and PAC standardization.

Note This affects buying comparisons and claim strength.

1/5
B
practical tolerability1

Juice products can add sugar and acidity, while capsules can concentrate extract. GI discomfort and adherence issues can matter more than the headline cranberry amount.

08

Legal and regulatory status

limited evidence wording2

United States context (as of 2026): FDA's qualified-health-claim enforcement discretion applies to specified cranberry juice beverages (at least 27% juice) and dietary supplements containing at least 500 mg of 100% cranberry fruit powder, with limited-evidence language. This is not a global rule, a general cranberry-product claim, or a claim about active symptoms.

09

Practical buying and quality notes

  • A 500 mg capsule without PAC disclosure is not directly comparable to a 37 mg PAC-standardized product. Ask for assay method, PAC type and batch matching.4
  • Cranberry juice cocktails can differ from unsweetened juice or extract products. Compare serving size, added sugars, concentration and PAC disclosure before comparing price.1
  • If a cranberry listing leads with focus, detox, brain fog or productivity claims, the claim is out of step with the stronger urinary-tract evidence base.3
10

FAQ

Is cranberry a nootropic?

9

Not established. Cranberry is better understood as a urinary-tract-focused food and extract ingredient. One small trial in healthy older adults reported a visual episodic-memory signal, but this does not establish a nootropic benefit.

Can cranberry replace UTI care?

1

No. Cranberry evidence is about recurrent-risk patterns in selected groups. Active urinary symptoms need appropriate medical assessment, especially with fever, flank pain, blood in urine, recurrent symptoms, or other higher-risk medical context.

What should buyers compare first?

4

Compare form, PAC disclosure, assay method, sugar load, serving size, kidney-stone and anticoagulant-drug cautions, test documentation and whether the label keeps claims within urinary-tract evidence.

11

References

  1. National Center for Complementary and Integrative Health. Cranberry.
  2. U.S. Food and Drug Administration. FDA Announces Qualified Health Claim for Certain Cranberry Products and Urinary Tract Infections.
  3. Williams G, Hahn D, Stephens JH, Craig JC, Hodson EM. Cranberries for preventing urinary tract infections. Cochrane Database Syst Rev. 2023;4(4):CD001321.
  4. Babar A, Moore L, Leblanc V, Dudonne S, Desjardins Y, Lemieux S, et al. High dose versus low dose standardized cranberry proanthocyanidin extract for the prevention of recurrent urinary tract infection in healthy women: a double-blind randomized controlled trial. BMC Urol. 2021;21(1):44.
  5. Stonehouse W, Benassi-Evans B, Bednarz J, Vincent AD. Whole cranberry fruit powder supplement reduces the incidence of culture-confirmed urinary tract infections in females with a history of recurrent urinary tract infection: a 6-month multicenter, randomized, double-blind, placebo-controlled trial. Am J Clin Nutr. 2025;121(4):932-941.
  6. Moro C, Phelps C, Veer V, Jones M, Glasziou P, Clark J, et al. Cranberry Juice, Cranberry Tablets, or Liquid Therapies for Urinary Tract Infection: A Systematic Review and Network Meta-analysis. Eur Urol Focus. 2024;10(6):947-957.
  7. Madden E, McLachlan C, Oketch-Rabah H, Calderon AI. Safety of Cranberry: Evaluation of Evidence of Kidney Stone Formation and Botanical Drug-Interactions. Planta Med. 2021;87(10-11):803-817.
  8. Ansell J, McDonough M, Zhao Y, Harmatz JS, Greenblatt DJ. The absence of an interaction between warfarin and cranberry juice: a randomized, double-blind trial. J Clin Pharmacol. 2009;49(7):824-830.
  9. Flanagan E, Cameron D, Sobhan R, Wong C, Pontifex MG, Tosi N, et al. Chronic Consumption of Cranberries (Vaccinium macrocarpon) for 12 Weeks Improves Episodic Memory and Regional Brain Perfusion in Healthy Older Adults: A Randomised, Placebo-Controlled, Parallel-Groups Feasibility Study. Front Nutr. 2022;9:849902.
Note

This page is informational and summarizes available evidence. It is not medical advice, a recommendation, or a substitute for guidance from a qualified clinician.